Roche: Sales at 14.93B Swiss francs in Q1, up 3% YoY

Wednesday, 21. April 2021 08:35

F. Hoffmann-La Roche AG revealed on Wednesday that its sales in the first fiscal quarter stood at 14.9 billion Swiss francs, increasing by 3% from the same trimester the previous year.

The company's pharmaceutical division recorded a 9% yearly decline in sales during the first three-month period in 2021. On the other hand, sales in the diagnostics division surged 55% year on year.

"The uptake of our recently introduced diagnostic tests and medicines remains strong, while we continue to see the expected impact from biosimilars on sales of our established medicines. Our broad product pipeline keeps making good progress... Based on the results of the first quarter of 2021, we confirm the outlook for the full year," CEO Severin Schwan commented.

Related Links: Roche Holding
Breaking the News / MS